spondylarthropathies/obesity

リンクがクリップボードに保存されます

ソートタイプを選択

ページ 1 から 72 結果

Obesity Increases Disease Activity of Norwegian Patients with Axial Spondyloarthritis: Results from the European Map of Axial Spondyloarthritis Survey

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

Objective: To investigate the prevalence of overweight and obesity, as well as the association between body mass index (BMI) and disease activity in patients with axial spondyloarthritis (axSpA). Methods:

The role of obesity on inflammation and damage in spondyloarthritis: a systematic literature review on body mass index and imaging.
登録ユーザーのみが記事を翻訳できます
ログインサインアップ

The objective of this systematic literature review was to evaluate the effect of obesity and/or body mass index (BMI) on radiographic findings of spondyloarthritis (SpA) for both axial and peripheral inflammation and damage.Medline, Embase and Cochrane

Do obesity and overweight influence disease activity measures in axial spondyloarthritis? A systematic review and meta-analysis
登録ユーザーのみが記事を翻訳できます
ログインサインアップ

Objective: the aim of our systematic review and meta-analysis was to investigate whether overweight/obesity are associated with higher disease activity measures in axial spondyloarthritis (axSpA) patients.

Association of obesity with patient-reported outcomes in patients with axial spondyloarthritis: a cross-sectional study in an urban Asian population.
登録ユーザーのみが記事を翻訳できます
ログインサインアップ

To determine if obesity is associated with poorer patient-reported outcomes (PROs) in patients with axial spondyloarthritis (axSpA), we conducted a cross-sectional study using data of the PRESPOND registry from a tertiary referral center in Singapore between 2011 and 2015. Demographics, clinical,

Influence of smoking and obesity on treatment response in patients with axial spondyloarthritis: a systematic literature review
登録ユーザーのみが記事を翻訳できます
ログインサインアップ

To assess whether smoking and obesity are predictors of poor treatment response in patients with axial spondyloarthritis (axSpA). A systematic literature review was performed by searching in MEDLINE and EMBASE up to June 2019 with a strategy based on the PICO approach: Population: patients with

Obesity Is Common in Axial Spondyloarthritis and Is Associated with Poor Clinical Outcome.
登録ユーザーのみが記事を翻訳できます
ログインサインアップ

OBJECTIVE To assess the prevalence of overweight and obesity in a large cohort of patients with axial spondyloarthritis (axSpA) in comparison with the general population. To explore the relationship of body mass index (BMI) with clinical outcome in axSpA. METHODS Patients from the Groningen

Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis.
登録ユーザーのみが記事を翻訳できます
ログインサインアップ

The aim of our study was to investigate the influence of conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) and body mass index (BMI) on circulating drug levels and clinical response to tumour necrosis factor inhibitor (TNFi) therapy in axial spondyloarthritis

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
登録ユーザーのみが記事を翻訳できます
ログインサインアップ

Few studies have investigated the impact of obesity on the response to tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (axSpA). The aim of our study was to investigate the impact of different body mass index (BMI) categories on TNFi response in a large cohort of

Patients with Spondyloarthritis and Obesity Who Fail TNF Antagonist Therapy: Change the Subcutaneous Injection Site before the Biologic?
登録ユーザーのみが記事を翻訳できます
ログインサインアップ

Obesity does not impair rehabilitation outcome in spondyloarthropathy.
登録ユーザーのみが記事を翻訳できます
ログインサインアップ

The relationship between weight status and metabolic syndrome in patients with rheumatoid arthritis and spondyloarthritis
登録ユーザーのみが記事を翻訳できます
ログインサインアップ

Objectives: To compare the prevalence and correlates of metabolic syndrome (MetS) stratified by body mass index (BMI) categories in rheumatoid arthritis (RA) and spondyloarthritis (SpA). Methods:

Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: data from COMOSPA.
登録ユーザーのみが記事を翻訳できます
ログインサインアップ

To analyze the potential association between the presence of HLA-B27 and the different comorbidities observed in Axial Spondyloarthritis patients.A comparative cross-sectional study including Axial Spondyloarthritis patients from COMOSPA registry. COMOSPA

Spondyloarthritis after bariatric surgery: is there a link?
登録ユーザーのみが記事を翻訳できます
ログインサインアップ

Presently, bariatric surgery is considered the most effective treatment for reducing excess body weight and maintaining weight loss in severely obese. On the other hand, several early and late complications have been described after this procedure. This article reports two patients who developed a

Axial Spondyloarthritis after bariatric surgery: a 7-year retrospective analysis.
登録ユーザーのみが記事を翻訳できます
ログインサインアップ

In recent decades, obesity has become a public health problem in many countries. The objective of this study was to evaluate the main joint and extra-articular manifestations related to spondyloarthritis (SpA) after bariatric surgery (BS) in a retrospective

Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment.
登録ユーザーのみが記事を翻訳できます
ログインサインアップ

OBJECTIVE Patients with spondyloarthritis (SpA) receiving anti-TNF-α treatment have an increase in fat mass. This may be relevant to cardiovascular risk. The aim of this study was to estimate visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) changes by dual-energy x-ray

Facebookページに参加する

Herbal & Natural Medicine
科学に裏打ちされた最も完全な薬草データベース
55の言語で動作します
科学に裏打ちされたハーブ療法
画像によるハーブの認識
インタラクティブGPSマップ-場所にハーブをタグ付け（近日公開）
検索に関連する科学出版物を読む
それらの効果によって薬草を検索する
あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください
症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

spondylarthropathies/obesity

Obesity Increases Disease Activity of Norwegian Patients with Axial Spondyloarthritis: Results from the European Map of Axial Spondyloarthritis Survey

The role of obesity on inflammation and damage in spondyloarthritis: a systematic literature review on body mass index and imaging.

Do obesity and overweight influence disease activity measures in axial spondyloarthritis? A systematic review and meta-analysis

Association of obesity with patient-reported outcomes in patients with axial spondyloarthritis: a cross-sectional study in an urban Asian population.

Influence of smoking and obesity on treatment response in patients with axial spondyloarthritis: a systematic literature review

Obesity Is Common in Axial Spondyloarthritis and Is Associated with Poor Clinical Outcome.

Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis.

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.

Patients with Spondyloarthritis and Obesity Who Fail TNF Antagonist Therapy: Change the Subcutaneous Injection Site before the Biologic?

Obesity does not impair rehabilitation outcome in spondyloarthropathy.

The relationship between weight status and metabolic syndrome in patients with rheumatoid arthritis and spondyloarthritis

Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: data from COMOSPA.

Spondyloarthritis after bariatric surgery: is there a link?

Axial Spondyloarthritis after bariatric surgery: a 7-year retrospective analysis.

Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment.

科学に裏打ちされた最も完全な薬草データベース